Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

1-(4-Methoxyphenyl)-1-Cyclopropanecarboxylic Acid

    • Product Name 1-(4-Methoxyphenyl)-1-Cyclopropanecarboxylic Acid
    • Alias MCPA
    • Einecs 696-195-5
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    568346

    Product Name 1-(4-Methoxyphenyl)-1-Cyclopropanecarboxylic Acid
    Cas Number 90984-94-4
    Molecular Formula C11H12O3
    Molecular Weight 192.21
    Appearance White to off-white solid
    Melting Point 102-105°C
    Solubility Insoluble in water; soluble in organic solvents
    Purity Typically ≥98%
    Storage Conditions Store at 2-8°C, protected from light and moisture
    Smiles COC1=CC=C(C=C1)C2(CC2)C(=O)O
    Inchi Key GGMNCWKDMTLOST-UHFFFAOYSA-N

    As an accredited 1-(4-Methoxyphenyl)-1-Cyclopropanecarboxylic Acid factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing Amber glass bottle, tamper-evident cap, white printed label displaying "1-(4-Methoxyphenyl)-1-Cyclopropanecarboxylic Acid, 5 grams, CAS #938062-67-0."
    Shipping Shipping of 1-(4-Methoxyphenyl)-1-Cyclopropanecarboxylic Acid is handled in compliance with relevant chemical transport regulations. The compound is securely packed in airtight containers to prevent contamination or leakage. Handling requires appropriate labeling and documentation to ensure safe transport. Shipment is typically arranged via ground or air, depending on destination and regulatory requirements.
    Storage Store **1-(4-Methoxyphenyl)-1-cyclopropanecarboxylic acid** in a cool, dry, and well-ventilated area away from sources of ignition and direct sunlight. Keep the container tightly closed when not in use. Avoid exposure to moisture and incompatible materials such as strong oxidizing agents. Ensure proper labeling, and store according to local chemical safety regulations.
    Application of 1-(4-Methoxyphenyl)-1-Cyclopropanecarboxylic Acid

    Applications of 1-(4-Methoxyphenyl)-1-Cyclopropanecarboxylic Acid in Industrial Manufacturing

    As the original producer, we supply 1-(4-Methoxyphenyl)-1-Cyclopropanecarboxylic Acid to global manufacturers who require strict traceability, lot consistency, and full transparency in their formulation chains. The following sections highlight key downstream sectors where our product enables advanced synthesis, all based on verifiable market practice and sector-specific standards.

    1. Pharmaceutical Intermediate for CNS-Active Compounds

    This raw material serves as a critical building block in the synthesis of central nervous system (CNS)-active molecules, especially those developed for neurological indications in branded and generic drug pipelines. Chiral cyclopropane carboxylic acid derivatives are widely utilized during key coupling and modification stages to form structures with improved metabolic stability and receptor selectivity. Researchers and process chemists integrate this intermediate into multi-step campaigns, optimizing dosage levels to maximize yield while minimizing enantiomeric impurity byproducts, addressing current GMP and regulatory expectations for small-molecule APIs.

    Industry compliance standards

    • ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
    • EU EudraLex Volume 4 for API starting materials
    • United States Pharmacopeia (USP) requirements for process impurities
    • FDA DMF (Drug Master File) submission standards

    Typical usage ratio

    • 5-14% of total reaction molar load, with adjustment based on desired throughput and chiral purity; chemists alter equivalents to tune conversion and regulatory impurity thresholds.

    Downstream process integration

    • Enters at the initial condensation or coupling step in API synthesis, often followed by asymmetrical reduction, functional group transformation, and subsequent purification steps.

    Final product types

    • Clinical-phase Active Pharmaceutical Ingredients (APIs) for CNS disorders
    • Marketed generics or branded small-molecule drugs with cyclopropane structures

    2. Advanced Agrochemical Synthesis

    Agrochemical formulators rely on this compound as a key precursor in manufacturing herbicide and pesticide actives with cyclopropane motifs, widely recognized for conferring plant selectivity and environmental persistence. The acid group’s reactivity supports selective esterification and halogenation, making it integral to multi-functionalization strategies in crop protection actives. Large-scale producers precisely monitor batch ratios to balance active ingredient content and minimize non-target residue during downstream formulation, ensuring compliance with contemporary residue and environmental safety standards globally.

    Industry compliance standards

    • FAO/WHO specifications for pesticide technical materials
    • OECD Guidelines for the Testing of Chemicals
    • REACH (EC 1907/2006) registration for environmental risk and hazard assessment
    • ISO 9001:2015 Quality Management for chemical processing

    Typical usage ratio

    • Ranges from 3-7% of total ingredient input in the main active synthesis batch; ratio modified based on target molecule and desired crop specificity profiles.

    Downstream process integration

    • Conversion as a core scaffold during the preparative alkylation or halogenation stages in technical-grade active manufacturing, followed by formulation into EC, WP, or SC end products.

    Final product types

    • Herbicidal and insecticidal actives featuring cyclopropane moieties
    • Formulated agrochemical emulsifiable concentrates (EC), wettable powders (WP), and suspension concentrates (SC)

    3. Specialty Fragrance Ingredient Production

    The cyclopropane-based aromatic structure enables the synthesis of fragrance intermediates where stability and persistence under differing pH or UV exposure conditions are essential. In specialty fragrance development, this acid reacts through controlled esterification or amidation, creating structural motifs valued in high-end personal care and fine fragrance oils. Producers aim for batch reproducibility and minimal off-notes, closely aligning their use of this acid to IFRA guidelines and adjusting concentrations in accord with the end-application’s volatility and olfactory character requirements.

    Industry compliance standards

    • International Fragrance Association (IFRA) Standards
    • EU Regulation (EC) No 1223/2009 on Cosmetic Products
    • ISO 16128 series for natural and organic cosmetic ingredients
    • Harmonized System for Hazard Communication (GHS) for downstream packaging

    Typical usage ratio

    • Utilized at 0.5-2.5% of total batch mass during intermediate manufacturing; the exact range is tailored to reactivity, target aroma note, and target dilution in finished products.

    Downstream process integration

    • Undergoes esterification or amidation within a closed-system batch reactor prior to blending with base oils or solvents for perfumery and personal care use.

    Final product types

    • Aromatic esters and amides for use in fine fragrance concentrates
    • Intermediate fragrance blocks for personal care applications such as body lotions, shampoos, and creams

    4. Fine Chemical Intermediate for Chiral Synthesis

    Manufacturers specializing in asymmetric synthesis incorporate this raw material for constructing libraries of enantiopure cyclopropane-based frameworks used in advanced organic synthesis and lead compound development. The precise management of configuration and reactivity during the carboxyl activation and nucleophilic substitution ensures high-fidelity transfer of chirality, essential for structure–activity relationship (SAR) studies and further derivatization. The choice of equivalents depends on the substrate scope and scale, matching high-throughput screening or gram-to-multi-kilogram pilot operations according to client demands under ISO quality systems.

    Industry compliance standards

    • ISO 9001:2015 Quality Management for custom synthesis
    • OECD Principles of Good Laboratory Practice (GLP) for research supply chains
    • Responsible Care® chemical product stewardship
    • UN Guidance for the Transport of Dangerous Goods (if shipped internationally)

    Typical usage ratio

    • Between 1-10% on a molar basis relative to the starting material, variably set according to the complexity of asymmetric induction and subsequent functional group installation steps.

    Downstream process integration

    • Introduced in the stage-selective formation of substituted cyclopropane rings via carboxyl activation, followed by reduction, addition, or diversification as required for SAR libraries.

    Final product types

    • Enantiomerically enriched intermediates for pharmaceutical R&D use
    • Reference compound libraries for contract research organizations (CROs)
    Free Quote

    Competitive 1-(4-Methoxyphenyl)-1-Cyclopropanecarboxylic Acid prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    1-(4-Methoxyphenyl)-1-Cyclopropanecarboxylic Acid: Practical Insights from Our Production Line

    Deep Dive into Our Synthesis and Quality Practices

    The reality of manufacturing 1-(4-Methoxyphenyl)-1-cyclopropanecarboxylic acid day in, day out teaches lessons unavailable from theory or second-hand sources. This molecule, often referenced as a critical intermediate in pharmaceutical and specialty chemical synthesis, demands a level of process attention that rewards experience at every turn. Over time, we’ve refined our process chemistry to consistently generate a product that holds up to not just chemical scrutiny, but to repeated industrial-scale transformations.

    To reach a consistent lot, we start with an understanding that the methoxy substituent on the phenyl ring significantly shapes both the synthetic route and the molecule’s behavior. Having worked with different aryl-cyclopropane carboxylic acid analogues, the 4-methoxy isn’t just about a structural quirk; it influences both reactivity and selectivity. This often gets overlooked by those unfamiliar with hands-on synthesis and scale-up.

    A process like Friedel-Crafts alkylation or cyclopropanation, when applied to a para-methoxy-substituted system, turns up idiosyncrasies not seen in other analogues—solvent choices, pH sensitivity, and even subtle shifts in byproduct formation. On a production scale, these observations lead us to tune purification steps beyond what’s outlined in literature. We filter, crystallize, and adjust washing solvents until repeat analyses—using GC and NMR—prove the batch aligns with specs. Each cycle of production feeds data back, letting us minimize waste and optimize yield.

    Talking Specification: Purity and Physical Profile

    As those measuring out the grams and kilos, we pay attention to batch color, crystalline habit, and even stubborn odors that sometimes pop up due to trace organics. Typical purity by HPLC checks in at over 99%. Melting point and water content get logged alongside every batch, not for show, but because out-of-spec readings usually point to contamination or a subtle shift in process conditions. Over the years, the demand for tight control on these figures didn’t come from a distant regulatory hand, but from the R&D and process chemists who rely on predictability.

    Particle size matters less for this compound compared to, say, API actives or catalysts—solubility in most polar organic solvents is consistent enough. But every so often a customer requires a custom granulometry for downstream handling, and this is when experience in drying and sieving shines. Too much milling generates static and fines, too little leaves chunky particles that can cake during shipping. Our team finds results smoother when the product leaves the dryer in a well-managed state, avoiding excessive intervention.

    Many Applications, Real-World Nuances

    1-(4-Methoxyphenyl)-1-cyclopropanecarboxylic acid rarely acts alone in a process. We’ve seen it move into everything from active pharmaceutical ingredient synthesis to advanced material science roles. For customers in the drug discovery pipeline, this compound often serves as a precursor in constructing more complex cyclopropane-containing scaffolds. Process teams value the combination of the rigid cyclopropane ring and the electronically modulated aryl group for fine-tuning pharmacokinetics.

    Producing kilograms of this compound, we learned the importance of minimizing carryover from related byproducts—especially those cyclopropane diacids or methylated regioisomers. Certain downstream reactions, including amidations and acylations, show noticeable efficiency drops with even single-digit ppm concentrations of these impurities. Our troubleshooting logs read like an evolving manual for purification—every deviation noted, and every successful tweak documented and sometimes adopted as a permanent shift to the SOP.

    Beyond pharmaceuticals, colleagues in agricultural chemistry have requested this compound for use as a building block in crop protection molecules. The 4-methoxy pattern confers a balance between reactivity and metabolic stability, and in field trials of resulting products, this structural feature delivers measurable differences in environmental persistence. We’ve also discussed with polymer scientists who are probing new synthetic routes for functionalized monomers, seeking the rigidity of the cyclopropane along with the polar modulation of the methoxy phenyl unit.

    Contrasts with Related Cyclopropane Carboxylic Acids

    Having synthesized and purified many cyclopropane carboxylic acids, we notice recurring themes that separate the 4-methoxyphenyl version from its kin. For instance, the 4-chlorophenyl and unsubstituted phenyl derivatives each bring different solubility, pKa, and reactivity profiles to the table. The methoxy group pushes electron density into the aromatic ring, which promotes certain coupling reactions but requires careful balancing in oxidative steps. Colleagues who take delivery of these other analogues have commented on the slightly greater ease of acyl chloride formation and subsequent amide synthesis with the unsubstituted variant—something we trace back to subtle electronic differences.

    Even during storage, the 4-methoxy analogue exhibits better color stability. We attribute this to both the electron-donating group and the comparative resistance to ambient oxidation, a frustration we see more with electron-withdrawing substituted analogues. End users who depend on colorless or off-white input materials tend to favor this variant if downstream formulations are sensitive to colored contaminants.

    Physically, the methoxy derivative tends to crystallize a bit more readily, which simplifies larger batch isolations. Its melting point sits above some para-substituted analogues but below the parent compound, letting us calibrate drying and packing steps to avoid melting or sintering during transit. Each season exposes new challenges—monsoon humidity, winter shipping delays—and our warehouse staff monitor these factors like clockwork, since batch integrity often hinges on minor adjustments.

    Process Control and Real-World Constraints

    Supplying industrial clients means more than hitting paperwork purity. Quality lives—or fails—on the edges: fine points like residual solvent content, trace inorganics, and even the way the compound behaves under pilot plant conditions. Many companies talk about “meeting requirements,” but direct experience with hundreds of cross-checked lots forced us to design real-time analytics into every run. Instrument uptime matters more than catalog promises. Teams stay late to rerun an out-of-spec sample, because the next synthesis down the line can be thrown off by contaminants that resist easy detection.

    We balance between maximizing throughput and tuning in details. With some aryl cyclopropane carboxylic acids, recovery after workup feels routine—four-fifths of theoretical yield, minimal losses. With this methoxy-substituted variant, filtration rates can lock up if minor pH drifts occur. Experience on the ground teaches that a small tweak—changing the base’s quench temperature or extending stirring by only half an hour—can double process efficiency. Paper protocols can’t substitute for the muscle memory and quick observation built over years of production.

    Clients working in discovery and scale-up projects ask us about batch reproducibility, not just purity. We track outcomes by lot and process parameters, charting every deviation and implementing Kaizen-style improvements so that as batch numbers climb into the tens and hundreds, outliers drop away from the norm.

    Supporting Researchers and Industry Practitioners

    Having a chemical that reacts the way it claims on paper makes a project schedule possible. Successes in our facility usually tie back to keeping an open line with researchers and process engineers. We pick up early warnings from clients—unexpected side reactions, solubility struggles, purification bottlenecks—and bring those observations into our feedback loop. If someone’s pilot batch produces a sticky residue or hazy crystals, more than one of our process techs has spent a weekend reconstructing the path, often replicating reported phenomena and adding data to the troubleshooting pool.

    In our experience, those who use this compound as a core building block in new molecule synthesis value consistent batch-to-batch release. We remember a project team pausing a major program due to unexplained yield drops—tracing it eventually to a subtle shift in trace water content from a supplier. Fixing the issue demanded not only better equipment but better communication with the end user. Such situations push us to invest in more robust drying and storage protocols, tracking lot history and validating process changes before release.

    Regulatory awareness grows every year. We track impurity profiles to ICH guidelines, but real-world safety hinges as much on traceability and transparency as formal paperwork. There are no shortcuts: cleaning logs, analytical run charts, and a culture of asking “why did this happen today?” rather than “who made the mistake?” ensure problems get solved quickly and lessons carry forward.

    Storage, Packaging, and Industry Feedback

    Our packs find their way from pharma R&D centers to pilot plants and sometimes back again as returned samples. Customers want predictable shelf life as much as chemical potency. Absorption of moisture or volatiles in transit, though rarely catastrophic, can mislead chemists on the receiving end. To address this, we worked side by side with supply chain partners to harden our packaging protocols—double-liners, vacuum sealing, and shipping under dry conditions became standard not from an external audit, but years of fielding calls from users stumped by unexplained behaviors.

    More than one client flagged issues with caking or static buildup in the product, particularly if they repackage or redistribute. We share best practices derived from handling thousands of containers, such as minimizing exposure to open air during transfer, or using grounded scoops to dissipate static. These tweaks come not from R&D manuals, but from warehouse and facility operators whose routine prevents field headaches.

    Another category of feedback: complaints when paperwork fails to match the actual container. Our compliance and warehouse staff double-file COAs with each shipment. Internal nonconformities often get caught here, driven by the knowledge that field errors, even if rare, can cost project teams days of troubleshooting and resynthesis.

    Logistics can shape user satisfaction as much as chemistry itself. Delays due to weather, customs, or internal bottlenecks prompt us to keep safety stocks. Shipping accuracy, responsiveness to rescheduling, and handling emergency requests have added depth to our process, going beyond meeting baseline requirements to anticipating points of failure.

    Looking Ahead: Adapting Through Direct Experience

    We see shifts in demand as discovery teams chase new candidates, or as regulation changes the business landscape. Occasionally batch failures or supply shortages force us to pivot and scale differently. New requests—whether for larger drums or improved documentation—drive continuous improvement as much as technical advances.

    The transition from pilot scale to regular production rarely happens seamlessly. We have absorbed missteps, learned the hard way about the limits of certain synthetic steps, and reworked purification trains in direct response to repeated observations. These lessons carry forward, informing improvements in automation, cleaning techniques, and even operator training.

    One thread runs through our ongoing work with 1-(4-Methoxyphenyl)-1-cyclopropanecarboxylic acid: adjustments based on lived experience. No amount of formal specification or generic technical data matches the insights gained from adapting day after day, batch after batch, to deliver a compound that not only meets baseline expectations but also supports real-world, innovative chemistry.

    This compound’s journey from synthesis to application is shaped by a thousand small decisions. Those choosing a source benefit from a manufacturer grounded not just in regulatory compliance or theoretical expertise, but in the discipline and responsibility that only sustained, hands-on production provides.